Carbonic anhydrase II is induced in HL-60 cells by 1,25-dihydroxyvitamin D3: A model for osteoclast gene regulation by Shapiro, Linda Hillstrom et al.
Volume 249, number 2, 307-310 FEB 07218 June 1989 
Carbonic anhydrase II is induced in HL-60 cells by 
1,25-dihydroxyvitamin D 3" a model for osteoclast gene regulation 
L i n d a  H i l l s t r o m  Shap i ro* ,  Pa t r i ck  J. Ven ta* ,  Y a - S h i o u  L. Y u  and  R i c h a r d  E. T a s h i a n  
Department of  Human Genetics, University of  Michigan, Medical School, Ann Arbor, M148109-0618, USA 
Received 5 April 1989 
Carbonic anhydrase II (CA II) generates the H ÷ required for osteoelast-mediated bone resorption in humans. We have 
developed the human promyelocytic cell line HL-60 as a model system with which to study the osteoclast-specific expres- 
sion of the CA II gene. Treatment of the cell line with 1,25-dihydroxyvitamin D 3 resulted in a dramatic de novo induction 
of CA II at both the protein and mRNA levels. CA II mRNA was also induced to a lesser extent by 12-O-tetradecanoyl 
phorbol 13-acetate. Treatment with dimethyl sulfoxide did not increase CA II mRNA. These findings indicate that the 
HL-60 cell line will be a useful model system to study the osteoclast-speeific expression of the CA II gene. 
Carbonic anhydrase II; Osteoclast; Dihydroxyvitamin D3, 1,25-; (HL-60 cell) 
1. I N T R O D U C T I O N  
Carbonic anhydrase (CA, EC 4.2.1.1) catalyzes 
the interconversion of  carbon dioxide and water to 
bicarbonate and protons.  A considerable amount  
of  information is known about  the molecular 
structures, genetics, evolution, and physiological 
roles of  the different CA isozymes [1]. In mam-  
mals, the CA isozymes are coded by at least seven 
genes, designated CA I - C A  VII,  which in general 
have different tissue specificities and probably 
varying physiological roles [2]. In humans,  an in- 
herited deficiency of  CA II  (CA II  deficiency syn- 
drome) is characterized by osteopetrosis, renal 
tubular  acidosis, and cerebral calcification [3] and 
in mice by renal tubular acidosis [4] and vascular 
calcifications [5]. The osteopetrosis in CA II  defi- 
ciency syndrome is an osteoclast-specific defect as 
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shown by two lines of  evidence. CA II  in bone is 
found only in osteoclasts in a variety of  species 
[6-10],  and variation in the activity of  CA II  
caused by hormonal  t reatment (e.g. parathyroid 
hormone)  in bone culture influences the degree of  
bone resorption [11]. 
Because the study of  CA II gene regulation at 
the molecular level is hampered by the difficulty of  
obtaining a sufficient number  of  purified 
osteoclasts, a model cell culture system is needed. 
Since there is a close developmental relationship 
between osteoclasts and macrophages and 
monocytes [12], it might be possible to study CA 
II  gene regulation in a cell line derived f rom the lat- 
ter cell types. The HL-60 cell line, derived f rom a 
patient with promyelocytic leukemia, can be in- 
duced to undergo monocytic differentiation by a 
variety of  compounds [13] including 1,25-dihy- 
droxyvitamin D3 [I,25-(OH)2D3], a hormone 
known to affect strongly bone resorption [14]. 
Trace levels of  CA II have been found in unin- 
duced HL-60 cells [15]. We reasoned that this cell 
line might provide a potential model for the regula- 
t ion of  the CA II  gene in the osteoclast, and that 
CA II  might be induced to higher levels by expos- 
ing the cells to 1,25-(OH)2D3. It is shown here that 
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such an induction does occur for both CA II 
m R N A  and protein. 
2. MATERIALS A N D  METHODS 
2.1. Cell culture and treatments 
HL-60 cells were grown in RPMI-1640 medium with 10% 
fetal calf serum. Cells were induced with 1,25-(OH)2D3, 12-0- 
tetradecanoyl phorbol 13-acetate (TPA), or dimethyl sulfoxide 
(DMSO) for varying lengths of time as described in the figure 
legends. The concentrations were 10 nM 1,25-(OH)2D3, 10 nM 
TPA and 1.25°70 DMSO. 
2.2. Northern blots 
RNA was isolated by a guanidine-HC1 procedure [16]. RNAs 
(10/~g per lane, except as noted) were run in formaldehyde gels 
and transferred to nylon membranes by capillary blotting [17]. 
The amount of RNA loaded was confirmed by ethidium 
bromide staining. Blots were probed with randomly primed [ 18] 
human CA II cDNA [19], washed and autoradiographed. Some 
blots were also probed with human CA I [20], CA III [21], and 
CA VII DNAs [22]. 
2.3. Western blots 
Cell lysates were prepared by freeze-thawing cells in 
phosphate-buffered saline and pelleting the debris. 50/~g pro- 
tein per lane were run on SDS gels, transferred to a nylon mem- 
brane [23], and probed with rabbit anti-human CA II followed 
by goat anti-rabbit IgG conjugated to alkaline phosphatase. 
Blots were developed with nitroblue tetrazolium and 
bromochloroindoyl phosphate [24]. 
Fig.1. Northern blot showing effect of 1,25-(OH)zD3, TPA, 
and DMSO on CA II induction in HL-60 cells. All lanes 
contained 10/zg total RNA except lane 3 which had 25/zg total 
RNA. HL-60 cells were treated for 48 h with each inducing 
agent at the concentrations given in section 2. Lanes: (1) 
uninduced, (2,3) induced with 1,25-(OH)2D3, (4) induced with 
DMSO, (5) induced with TPA. The blot was probed with the 
cloned human CA II cDNA [14]. 
2.4. Cellulose acetate electrophoresis 
Human CA I and CA II were purified from hemolysates by 
affinity chromatography as described [25]. Cellulose acetate 
electrophoresis, using a buffer composed of 0.44 M Tris, 
50 mM boric acid, and 15 mM EDTA at pH 9.1, was perform- 
ed at 300 V for 3 h [26]. Carbonic anhydrase activity was 
detected by a CO2-driven indicator (bromothymol blue) color 
change as described in [27]. 
3. RESULTS 
3.1. CA H mRNA is induced by 
1,25-dihydroxyvitamin 193 
The treatment of  HL-60 cells with 1,25-(OH)2Da 
or TPA,  another reagent commonly used to induce 
HL-60 cells along a monocytic differentiation 
pathway, results in the induction of  CA II m R N A  
after 48 h incubation (fig.l).  However,  treatment 
of  the cells with DMSO, which causes HL-60 cells 
to undergo granulocytic differentiation [13], does 
not result in induction of  CA II mRNA.  Den- 
sitometric scans of  the lanes give estimates of  a 
5-fold increase of  TPA-induced CA II  message and 
a 20-fold increase with 1,25-(OH)2Da after 48 h. 
The blot was also probed with human CA I, CA 
III ,  and CA VII DNAs. No signal was obtained 
with any of  these probes (not shown). Probes for 
other CA isozymes are not yet available. 
3.2. Rate o f  CA H mRNA induction 
The time course of  the change in CA II  m R N A  
levels in HL-60 cells was determined after treat- 
ment with TPA, 1,25-(OH)2D3, and DMSO. The 
CA II mRNA levels in TPA-treated cells appear to 
peak at 48 h and decrease slightly at 72 and 96 h 
(fig.2). No increase in CA II m R N A  was detected 
after 3 h exposure to 1,25-(OH)2D3; however, an 
increase was detected at 24 h, which continued to 
rise up to 96 h (fig.2). CA II m R N A  levels were not 
observed to change f rom control levels throughout  
96 h of  treatment with DMSO (not shown). 
3.3. CA H protein is induced by 
1,25-dihydroxyvitamin Ds 
Several Western blots of  treated HL-60 cell 
lysates were carried out, and a representative blot 
308 
Volume 249, number 2 FEBS LETTERS June 1989 
1 2 3 4 5 6 7 8 .... 9 1 0 1 1 1 2  
Fig.2. TPA and 1,25-(OH)2D3 time courses of CA I1 mRNA 
induction in HL-60 cells shown by Northern blot analysis. Cells 
were induced under standard conditions as described in the text 
and harvested at various times. Lanes: (1,6) control ceils, (2-5) 
treated with TPA, (7-12) treated with 1,25-(OH)2D~. Times of 
treatment: (2,9) 24 h, (3,10) 48 h, (4,11) 72 h, (5,12) 96 h, (7) 
1 h, (8) 3 h. 
is shown in fig.3.  A t race  a m o u n t  o f  C A  II p ro te in  
can  be seen in con t ro l  cells, and  an equiva lent  
a m o u n t  can be observed  in 72 and  96 h D M S O -  
t r ea ted  lysates.  In  con t ras t ,  an  app rox .  10-fold in- 
crease  in C A  II  p ro te in  can  be seen in 72 and  96 h 
1,25-(OH)2D3-induced lysates.  N o  increase  in C A  
II  p r o t e in  cou ld  be de tec ted  at  48 h o f  t r ea tmen t  
wi th  1,25-(OH)2D3 (not  shown) .  W h e n  c o m p a r e d  
to  k n o w n  amoun t s  o f  pur i f i ed  h u m a n  C A  II ,  it was 
e s t ima ted  tha t  50 ng C A  II  was present  at 96 h o f  
i nduc t i on  in 50/zg soluble  pro te in .  
Fig.4. Cellulose acetate electrophoresis of cell lysates stained 
for carbonic anhydrase activity at various times of treatment 
with 1,25-(OH)2D3. Lanes: (1) purified human CA I control; 
(2) purified human CA II control. Remaining lanes of induced 
lysate: (3) 0 h, (4) 24 h, (5) 48 h, (6) 72 h, (7) 96 h. 
3.4. CA H appears to be the only CA in HL-60 
cells 
To con f i rm  the  iden t i ty  o f  the i sozyme as C A  II ,  
lysates  were run  on  a cel lulose aceta te  m e m b r a n e  
and  s ta ined  for  ca rbon ic  anhydra se  ac t iv i ty  (fig.4).  
A n  increase  in ac t iv i ty  can  be de tec ted  at  72 and  
96 h in a b a n d  tha t  co-migra tes  with C A  II ,  bu t  no t  
wi th  C A  I. N o  increase  in C A  II ac t iv i ty  can be 
1 2 ...... 3 . . . . . .  4 5 
Fig.3. Western blot of cell lysates from DMSO- and 
1,25-(OH)2Drtreated ceils. 50/zg protein were loaded per lane. 
(1) Control cells; (2) DMSO, 72 h; (3) DMSO, 96 h; (4) 
1,25-(OH)2D3, 72 h; (5) 1,25-(OH)2D3, 96 h. 
obse rved  at 48 h (not  shown) .  C A  I I I  migra tes  to  
a no the r  pos i t ion  in this system,  bu t  because  o f  its 
subs tan t i a l ly  lower  ca rbonic  anhydra se  act ivi ty  
[28], it was not  inc luded in this  exper iment .  
4. D I S C U S S I O N  
W e  have deve loped  a m o d e l  cell cul ture  system 
which  can  be used to  s tudy  the os teoclas t -speci f ic  
r egu la t ion  o f  the  h u m a n  C A  II gene. HL-60  cells 
r e s p o n d  to a var ie ty  o f  h o r m o n e s  tha t  also effect  
bone  m e t a b o l i s m  [12,13]. The  effect  o f  these hor -  
mones  on  the r egu la t ion  o f  the  C A  II  gene can now 
be s tud ied  at  the  molecu la r  level. A l t h o u g h  HL-60  
cells express  C A  II ,  this  is no t  so in cu l tu red  ra t  
pe r iphe ra l  monocy te s ,  and  mos t  types  o f  mac ro -  
phages  [8]. Cons ide r ing  the close deve lopmen ta l  
re la t ionsh ips  be tween os teoclas ts  and  monocy tes  
a n d  ma c ropha ge s ,  as well as the  somet imes  aber-  
ran t  na tu re  o f  genet ic  p r o g r a m s  o f  neoplas t ic  cells, 
these results  are  no t  surpr is ing.  Both  os teoclas ts  
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a n d  HL-60  cells a p p e a r  to express only  the  C A  II 
i sozyme.  
The  h u m a n  and  mouse  C A  II  genes have been 
c loned  and  thei r  p r o m o t e r  regions  sequenced [29]. 
The  p r o m o t e r  lies wi th in  a GC-r i ch  is land,  and  the 
m i n i ma l  e lements  requi red  for  high-level  expres-  
s ion  in h u m a n  H e L a  cells and  mouse  L cells have 
been  ident i f ied  [30]. However ,  p r e l im ina ry  ex- 
pe r imen t s  in which the min ima l  p r o m o t e r  has been 
t r ans fec ted  into  HL-60  ceils has  shown tha t ,  
a l t hough  the T P A - r e s p o n s i v e  e lement  is present ,  
the  1 ,25 - (OH)2Dr respons ive  e lement  lies outs ide  
o f  this  reg ion  ( L . H . S .  and  P . J . V . ,  unpubl i shed) .  
Since l i t t le is k n o w n  a b o u t  how 1,25-(OH)2Da 
affects  the  express ion  o f  genes at  the  molecu la r  
level, this mode l  system should  p rov ide  some 
va luab le  insights  in to  the  r egu la to ry  effects  o f  this 
h o r m o n e .  Once the regu la t ion  o f  the  C A  II  gene is 
u n d e r s t o o d  in HL-60  cells, cri t ical  exper iments  can 
be  des igned to  examine  its r egu la t ion  in l imi ted  
a m o u n t s  o f  pur i f ied  os teoclas ts .  In  add i t ion ,  the  
results  ob t a ined  m a y  be useful  for  deve loping  a 
successful  gene rep lacement  t he r apy  o f  the  recent ly  
descr ibed  C A  I I -def ic ien t  mouse  mode l  [4]. 
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